A neutralizing anti-gH/gL monoclonal antibody is protective in the guinea pig model of congenital CMV infection.
A neutralizing anti-gH/gL monoclonal antibody is protective in the guinea pig model of congenital CMV infection.
复制标题
DOI：
10.1371/journal.ppat.1004060
复制
发表时间：
2014-04
期刊：
影响因子：
6.7
通讯作者：
Feierbach B
中科院分区：
文献类型：
--
作者：
Auerbach MR;Yan D;Vij R;Hongo JA;Nakamura G;Vernes JM;Meng YG;Lein S;Chan P;Ross J;Carano R;Deng R;Lewin-Koh N;Xu M;Feierbach B
Human cytomegalovirus (HCMV) is the most common cause of congenital virus infection. Congenital HCMV infection occurs in 0.2–1% of all births, and causes birth defects and developmental abnormalities, including sensorineural hearing loss and developmental delay. Several key studies have established the guinea pig as a tractable model for the study of congenital HCMV infection and have shown that polyclonal antibodies can be protective. In this study, we demonstrate that an anti-guinea pig CMV (GPCMV) glycoprotein H/glycoprotein L neutralizing monoclonal antibody protects against fetal infection and loss in the guinea pig. Furthermore, we have delineated the kinetics of GPCMV congenital infection, from maternal infection (salivary glands, seroconversion, placenta) to fetal infection (fetus and amniotic fluid). Our studies support the hypothesis that a neutralizing monoclonal antibody targeting an envelope GPCMV glycoprotein can protect the fetus from infection and may shed light on the therapeutic intervention of HCMV congenital infection in humans. Human cytomegalovirus (HCMV) is the most common cause of congenital virus infection and causes developmental abnormalities, including hearing loss and developmental delay. Although there is no therapy for congenital HCMV disease, there is evidence from both human and animal studies that antibodies can have efficacy in this setting. Such studies have focused exclusively on polyclonal antibodies, in which the targets of protective antibodies are unknown. Guinea pigs have been used as a model of human maternal fetal transmission of infection because of similarities in placental anatomy between human and guinea pig. Furthermore, guinea pig CMV (GPCMV) has been demonstrated to cross the placenta and cause fetal infection and loss, similar to the effects of infection with HCMV. However, the kinetics of maternal and fetal infection in this model has not been carefully investigated. In this work, we have delineated the kinetics of maternal to fetal infection and found that congenital infection is rapid following maternal infection. Importantly, we demonstrate that a monoclonal antibody against a protein critical for viral entry protects pregnant guinea pigs against fetal infection. Thus, our studies may be informative for development of a therapeutic intervention to treat congenital HCMV infection in humans.
登录
查看更多内容
影响因子：
3.7
作者：
Auerbach, Marcy;Yan, Donghong;Feierbach, Becket
通讯作者：
Feierbach, Becket
影响因子：
5.4
作者：
BIA, FJ;SUMMERS, WC;HSIUNG, GD
通讯作者：
HSIUNG, GD
影响因子：
3.7
作者：
Lilleri D;Kabanova A;Revello MG;Percivalle E;Sarasini A;Genini E;Sallusto F;Lanzavecchia A;Corti D;Gerna G
通讯作者：
Gerna G
影响因子：
5.4
作者：
Macagno, Annalisa;Bernasconi, Nadia L.;Lanzavecchia, Antonio
通讯作者：
Lanzavecchia, Antonio
影响因子：
3.1
作者：
Bakardjiev, AI;Stacy, BA;Portnoy, DA
通讯作者：
Portnoy, DA